Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Drugmakers condemn judge’s suspension of abortion pill access

The uncertainty the ruling creates could have a big impact on the pharmaceutical industry for years to come. 

Thumbnail

Abortion pill legality in question after conflicting federal judgments

The use of a common medication used to end pregnancy is now in question after a federal judge in Texas struck down its legality in a shocking decision.

Coalition for Health AI

Coalition acts to ensure credible, fair, transparent AI in healthcare

Having identified an “urgent” need for guardrails to keep healthcare AI from veering into an avoidable ditch, the Coalition for Health AI has put together a 24-page guide applicable to numerous groups of stakeholders.

the words "FDA recall" on a board

FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.

Thumbnail

Industry groups applaud bill connecting Medicare payments to inflation

Healthcare groups are applauding a bill in the House of Representatives that would ensure Medicare payments are tied to inflation.

board room table trustee directors

Cano Health leadership team in disarray after directors resign

Billionaire Barry Sternlicht, founder and CEO of Starwood Capital Group, was one of the board members who resigned.

Thumbnail

Johnson & Johnson offers nearly $9B to settle talc lawsuits

Johnson & Johnson has offered to pony up $8.9 billion over 25 years to settle all current and future claims that its talc baby powder contained asbestos and caused cancer to some consumers. It is one of the largest consumer liability settlements in history.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

Too much too soon? Elon Musk, other tech leaders pause AI development to review ethics

Healthcare is one of the biggest areas of opportunity for AI, with more than 500 health AI algorithms cleared by the FDA over the last several years.

Displaying 393 - 400 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup